SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S8 - Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
5:05 PM - 5:30 PM Discussion Andrew Southerland MD 

Disclosures

Speaker Disclosure
Andrew Mebane Southerland, MD Dr. Southerland has received personal compensation in an editorial capacity for Neurology podcast.

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Impact of hyperglycemia according to collateral status on reperfusion and outcomes in acute ischemic stroke after mechanical thrombectomy Joon-Tae Kim
Disclosure:
Dr. Kim has nothing to disclose.

3:42 PM 002 Ultra-short door-to-needle times of 10 minutes or less in stroke thrombolysis – experience from 63 cases Raffi Topakian, MD
Disclosure:
Dr. Topakian has received personal compensation for activities with Novartis and Shire-Baxalta as an advisory board member, from Novartis, Pfizer, Abbvie, and Bayer for conference support, and from Pfizer as a speaker.

3:54 PM 003 Impact of Neurologist In-Hospital 24/7 on stroke patients arriving to the Emergency Department activated as a Code Stroke Alexander Schneider, MD
Disclosure:
Dr. Schneider has nothing to disclose.

4:06 PM 004 An analysis of fixed dose IV recombinant tissue plasminogen activator (rtPA) and clinical outcomes in acute ischemic stroke patients with body weight >100 kilograms: pooled data from three randomized clinical trials Shahram Majidi, MD
Disclosure:
Dr. Majidi has nothing to disclose.

4:18 PM 005 The effect of baseline blood pressure on the benefit and safety of intra-arterial treatment in MR CLEAN. Maxim Mulder
Disclosure:
Dr. Mulder has nothing to disclose.

4:30 PM 006 Reliability of automated software to assign e-ASPECTS to CT scans for acute ischemic changes Lisa C Hoyte
Disclosure:
Dr. Hoyte has nothing to disclose.

4:42 PM 007 Thrombectomy and thrombolysis in pediatric acute ischemic stroke Kathryn Ess, MD
Disclosure:
Dr. Ess has nothing to disclose.

4:54 PM 008 Disruption of the Blood-Ocular Barriers in Stroke Patients Emi Hitomi
Disclosure:
Dr. Hitomi has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

1:30 PM-3:30 PM
C21 Stroke in Young Adults and Women Aneesh Singhal MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C29 Controversies in Stroke Treatment and Prevention Steven Messe MD, FAAN, FAHA

Monday April 23, 2018

7:00 AM-9:00 AM
C64 Update on Medical Management of Stroke Natalia Rost MD, MPH, FAAN
1:00 PM-3:00 PM
C75 Therapeutic Temperature Modulation in the ICU Stephan Mayer MD

Tuesday April 24, 2018

1:00 PM-3:00 PM
C114 Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
3:30 PM-5:30 PM
C128 Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Philip Gorelick MD, MPH, FAAN

Wednesday April 25, 2018

1:00 PM-3:00 PM
C150 Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Philip Gorelick MD, MPH, FAAN
3:30 PM-5:30 PM
C165 Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD

Thursday April 26, 2018

1:00 PM-3:00 PM
C194 Spanish: Update on Stroke Therapy Carlos Kase MD, FAAN, FAHA
3:30 PM-5:30 PM
C202 Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN

Friday April 27, 2018

7:00 AM-9:00 AM
C216 Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Seemant Chaturvedi MD, FAAN, FAHA

MEMBER LOG IN

Forgot Password?